CNS outcomes of lazertinib vs gefitinib in EGFR-mutated advanced NSCLC: A LASER301 subset analysis

Basit Öğe Kaydı
dc.authoridBondarenko, Igor/0000-0002-7071-2471
dc.authorwosidBondarenko, Igor/U-5156-2017
dc.contributor.authorSoo, R. A.
dc.contributor.authorCho, B. C.
dc.contributor.authorKim, J-H.
dc.contributor.authorAhn, M-J.
dc.contributor.authorLee, K. H.
dc.contributor.authorZimina, A.
dc.contributor.authorOrlov, S.
dc.date.accessioned2024-06-12T11:20:23Z
dc.date.available2024-06-12T11:20:23Z
dc.date.issued2023
dc.departmentTrakya Üniversitesien_US
dc.descriptionAnnual Meeting of the European-Society-for-Medical-Oncology (ESMO) -- OCT 20-24, 2023 -- Barcelona, SPAINen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipEuropean Soc Med Oncolen_US
dc.description.sponsorshipYuhan Corporationen_US
dc.description.sponsorshipYuhan Corporation.en_US
dc.identifier.doi10.1016/j.annonc.2023.09.2357
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.urihttps://doi.org/10.1016/j.annonc.2023.09.2357
dc.identifier.urihttps://hdl.handle.net/20.500.14551/25586
dc.identifier.volume34en_US
dc.identifier.wosWOS:001087480202001en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofAnnals Of Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleCNS outcomes of lazertinib vs gefitinib in EGFR-mutated advanced NSCLC: A LASER301 subset analysisen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu